Literature DB >> 9393815

Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha.

P A Gulig1, T J Doyle, M J Clare-Salzler, R L Maiese, H Matsui.   

Abstract

The spv genes of the virulence plasmid of Salmonella typhimurium and other nontyphoidal serovars of S. enterica are involved in systemic infection by increasing the replication rate of the bacteria in host tissues beyond the intestines. We considered the possibility that the Spv virulence function is to evade suppression by the host response to infection. To examine this possibility, gamma interferon (IFN-gamma) and/or tumor necrosis factor alpha (TNF-alpha) were neutralized in BALB/c mice by intraperitoneal administration of monoclonal antibodies. Neutralization of IFN-gamma and/or TNF-alpha resulted in increased splenic infection with wild-type salmonellae after oral inoculation; however, Spv- salmonellae were defective at increasing splenic infection in cytokine-depleted mice. The use of a temperature-sensitive marker plasmid, pHSG422, indicated that neutralization of IFN-gamma caused less killing of wild-type S. typhimurium, while neutralization of TNF-alpha resulted in an increased in vivo replication rate for wild-type salmonellae. These results demonstrate that the Spv virulence function is not to evade suppression of bacterial infection normally mediated by IFN-gamma or TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393815      PMCID: PMC175748          DOI: 10.1128/iai.65.12.5191-5197.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  The role of IFN-gamma in murine Salmonella typhimurium infection.

Authors:  A Muotiala; P H Mäkelä
Journal:  Microb Pathog       Date:  1990-02       Impact factor: 3.738

2.  Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.

Authors:  K C Sheehan; N H Ruddle; R D Schreiber
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  Plasmid-associated virulence of Salmonella typhimurium.

Authors:  P A Gulig; R Curtiss
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing.

Authors:  W H Benjamin; P Hall; S J Roberts; D E Briles
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

5.  Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth.

Authors:  M T Fallon; W H Benjamin; T R Schoeb; D E Briles
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Specific-purpose plasmid cloning vectors. I. Low copy number, temperature-sensitive, mobilization-defective pSC101-derived containment vectors.

Authors:  T Hashimoto-Gotoh; F C Franklin; A Nordheim; K N Timmis
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

7.  In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice.

Authors:  P Jacobs; D Radzioch; M M Stevenson
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  The involvement of tumor necrosis factor in immunity to Salmonella infection.

Authors:  J P Tite; G Dougan; S N Chatfield
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

9.  Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Authors:  N A Buchmeier; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Unraveling the secret lives of bacteria: use of in vivo expression technology and differential fluorescence induction promoter traps as tools for exploring niche-specific gene expression.

Authors:  Hans Rediers; Paul B Rainey; Jos Vanderleyden; René De Mot
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

2.  Influence of the Salmonella typhimurium pathogenicity island 2 type III secretion system on bacterial growth in the mouse.

Authors:  J E Shea; C R Beuzon; C Gleeson; R Mundy; D W Holden
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Norepinephrine augments Salmonella enterica-induced enteritis in a manner associated with increased net replication but independent of the putative adrenergic sensor kinases QseC and QseE.

Authors:  Gillian D Pullinger; Sonya C Carnell; Fathima F Sharaff; Pauline M van Diemen; Francis Dziva; Eirwen Morgan; Mark Lyte; Primrose P E Freestone; Mark P Stevens
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

4.  Analysis of host cells associated with the Spv-mediated increased intracellular growth rate of Salmonella typhimurium in mice.

Authors:  P A Gulig; T J Doyle; J A Hughes; H Matsui
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha.

Authors:  T Yamamoto; H Sashinami; A Takaya; T Tomoyasu; H Matsui; Y Kikuchi; T Hanawa; S Kamiya; A Nakane
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection.

Authors:  A A Fadl; J Sha; G R Klimpel; J P Olano; D W Niesel; A K Chopra
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 7.  Salmonella enterica serotype Choleraesuis: epidemiology, pathogenesis, clinical disease, and treatment.

Authors:  Cheng-Hsun Chiu; Lin-Hui Su; Chishih Chu
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Virulence plasmid-borne spvB and spvC genes can replace the 90-kilobase plasmid in conferring virulence to Salmonella enterica serovar Typhimurium in subcutaneously inoculated mice.

Authors:  H Matsui; C M Bacot; W A Garlington; T J Doyle; S Roberts; P A Gulig
Journal:  J Bacteriol       Date:  2001-08       Impact factor: 3.490

9.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

10.  Systemic and local cytokine response of young piglets to oral infection with Salmonella enterica serotype Typhimurium.

Authors:  I Trebichavský; I Splíchal; A Splíchalová; Y Muneta; Y Mori
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.